Deca Aloe’s exclusive formula provides physicians, health care practitioners, clinicians and consumers with a powerful new alternative and complementary therapy, used holistically or as an adjunct to standard orthodox conventional medical care, to speed the body’s own healing process.

Rather than the widely recognized Aloe vera, Deca Aloe only uses the rare Aloe arborescens botanical species for its remarkable healing components. Likewise, nothing but the purest raw honey, offering its own impressive roster of restorative compounds, is added to create this extraordinary formula.

Deca Aloe serves exploding end-markets driven by health and wellness consumer and medical trends with demonstrated growth in the 15 to 20% range. These trends include immune health, nutrition intervention therapy, and adjunctive medical food therapy.

North America is the largest market for immune health supplements, attributable to the rise of the number of health-conscious consumers.

The US market for immune support supplements was recorded at $1.7 billion, with an 8.8% CAGR, from 2013-2017.

The immune health supplements market is anticipated to record a CAGR of 7.5% over the forecast period. It is expected to attain the total market size of $28 billion by 2027. Vibrant growth by the end of the forecast period is projected.

Deca Aloe is committed to continuing to serve this market by introducing potent, innovative new products for consumers. Future plans include a new, advanced formula with added selenium, to focus specifically on cancer.

Plus, veterinary formulas for dogs, cats, horses and farm animals is currently in development. Together with physicians, health care practitioners and clinicians, Deca Aloe’s impact on chronic, degenerative illness has the potential to be transforming. The need, never greater than right now.